يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Th17 Cell"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    مؤتمر
    The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

    المؤلفون: Chevalier, Mf, Petitjean, Gaël, Didier, Céline, Girard, Philippe, Meyer, Laurence, Barré-Sinoussi, Françoise, Scott-Algara, Daniel, Weiss, Laurence

    المساهمون: Institut Pasteur Paris (IP), Régulation des Infections Rétrovirales, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: AIDS Vaccine 2012 ; https://inserm.hal.science/inserm-00731767Test ; AIDS Vaccine 2012, Sep 2012, Boston, United States. 9 (Suppl 2), pp.P285, 2012, ⟨10.1186/1742-4690-9-S2-P285⟩

    مصطلحات موضوعية: Th17 Cell, Mucosal Damage, Soluble CD14, Systemic Immune Activation, Intracellular Cytokine Staining, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases

    جغرافية الموضوع: Boston, United States

    الوقت: Boston, United States

    العلاقة: inserm-00731767; https://inserm.hal.science/inserm-00731767Test; https://inserm.hal.science/inserm-00731767/documentTest; https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    الإتاحة: https://doi.org/10.1186/1742-4690-9-S2-P285Test
    https://inserm.hal.science/inserm-00731767Test
    https://inserm.hal.science/inserm-00731767/documentTest
    https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    مؤتمر
    The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

    المؤلفون: Chevalier, Mf, Petitjean, Gaël, Didier, Céline, Girard, Philippe, Meyer, Laurence, Barré-Sinoussi, Françoise, Scott-Algara, Daniel, Weiss, Laurence

    المساهمون: Institut Pasteur Paris (IP), Régulation des Infections Rétrovirales, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: AIDS Vaccine 2012 ; https://inserm.hal.science/inserm-00731767Test ; AIDS Vaccine 2012, Sep 2012, Boston, United States. 9 (Suppl 2), pp.P285, 2012, ⟨10.1186/1742-4690-9-S2-P285⟩

    مصطلحات موضوعية: Th17 Cell, Mucosal Damage, Soluble CD14, Systemic Immune Activation, Intracellular Cytokine Staining, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases

    جغرافية الموضوع: Boston, United States

    الوقت: Boston, United States

    العلاقة: inserm-00731767; https://inserm.hal.science/inserm-00731767Test; https://inserm.hal.science/inserm-00731767/documentTest; https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    الإتاحة: https://doi.org/10.1186/1742-4690-9-S2-P285Test
    https://inserm.hal.science/inserm-00731767Test
    https://inserm.hal.science/inserm-00731767/documentTest
    https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    مؤتمر
    The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

    المؤلفون: Chevalier, Mf, Petitjean, Gaël, Didier, Céline, Girard, Philippe, Meyer, Laurence, Barré-Sinoussi, Françoise, Scott-Algara, Daniel, Weiss, Laurence

    المساهمون: Institut Pasteur Paris (IP), Régulation des Infections Rétrovirales, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: AIDS Vaccine 2012 ; https://inserm.hal.science/inserm-00731767Test ; AIDS Vaccine 2012, Sep 2012, Boston, United States. 9 (Suppl 2), pp.P285, 2012, ⟨10.1186/1742-4690-9-S2-P285⟩

    مصطلحات موضوعية: Th17 Cell, Mucosal Damage, Soluble CD14, Systemic Immune Activation, Intracellular Cytokine Staining, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases

    جغرافية الموضوع: Boston, United States

    الوقت: Boston, United States

    العلاقة: inserm-00731767; https://inserm.hal.science/inserm-00731767Test; https://inserm.hal.science/inserm-00731767/documentTest; https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    الإتاحة: https://doi.org/10.1186/1742-4690-9-S2-P285Test
    https://inserm.hal.science/inserm-00731767Test
    https://inserm.hal.science/inserm-00731767/documentTest
    https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    مؤتمر
    The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

    المؤلفون: Chevalier, Mf, Petitjean, Gaël, Didier, Céline, Girard, Philippe, Meyer, Laurence, Barré-Sinoussi, Françoise, Scott-Algara, Daniel, Weiss, Laurence

    المساهمون: Institut Pasteur Paris (IP), Régulation des Infections Rétrovirales, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: AIDS Vaccine 2012 ; https://inserm.hal.science/inserm-00731767Test ; AIDS Vaccine 2012, Sep 2012, Boston, United States. 9 (Suppl 2), pp.P285, 2012, ⟨10.1186/1742-4690-9-S2-P285⟩

    مصطلحات موضوعية: Th17 Cell, Mucosal Damage, Soluble CD14, Systemic Immune Activation, Intracellular Cytokine Staining, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases

    جغرافية الموضوع: Boston, United States

    الوقت: Boston, United States

    العلاقة: inserm-00731767; https://inserm.hal.science/inserm-00731767Test; https://inserm.hal.science/inserm-00731767/documentTest; https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    الإتاحة: https://doi.org/10.1186/1742-4690-9-S2-P285Test
    https://inserm.hal.science/inserm-00731767Test
    https://inserm.hal.science/inserm-00731767/documentTest
    https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    مؤتمر
    The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

    المؤلفون: Chevalier, Mf, Petitjean, Gaël, Didier, Céline, Girard, Philippe, Meyer, Laurence, Barré-Sinoussi, Françoise, Scott-Algara, Daniel, Weiss, Laurence

    المساهمون: Institut Pasteur Paris (IP), Régulation des Infections Rétrovirales, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: AIDS Vaccine 2012 ; https://inserm.hal.science/inserm-00731767Test ; AIDS Vaccine 2012, Sep 2012, Boston, United States. 9 (Suppl 2), pp.P285, 2012, ⟨10.1186/1742-4690-9-S2-P285⟩

    مصطلحات موضوعية: Th17 Cell, Mucosal Damage, Soluble CD14, Systemic Immune Activation, Intracellular Cytokine Staining, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases

    جغرافية الموضوع: Boston, United States

    الوقت: Boston, United States

    العلاقة: inserm-00731767; https://inserm.hal.science/inserm-00731767Test; https://inserm.hal.science/inserm-00731767/documentTest; https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    الإتاحة: https://doi.org/10.1186/1742-4690-9-S2-P285Test
    https://inserm.hal.science/inserm-00731767Test
    https://inserm.hal.science/inserm-00731767/documentTest
    https://inserm.hal.science/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    مؤتمر
    The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

    المؤلفون: Chevalier, MF, Petitjean, Gaël, Didier, Céline, Girard, Philippe, Meyer, Laurence, Barré-Sinoussi, Françoise, Scott-Algara, Daniel, Weiss, Laurence

    المساهمون: Institut Pasteur Paris, Régulation des Infections Rétrovirales, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)

    المصدر: AIDS Vaccine 2012 ; https://www.hal.inserm.fr/inserm-00731767Test ; AIDS Vaccine 2012, Sep 2012, Boston, United States. 9 (Suppl 2), pp.P285, 2012, ⟨10.1186/1742-4690-9-S2-P285⟩

    مصطلحات موضوعية: Th17 Cell, Mucosal Damage, Soluble CD14, Systemic Immune Activation, Intracellular Cytokine Staining, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases

    جغرافية الموضوع: Boston, United States

    الوقت: Boston, United States

    العلاقة: inserm-00731767; https://www.hal.inserm.fr/inserm-00731767Test; https://www.hal.inserm.fr/inserm-00731767/documentTest; https://www.hal.inserm.fr/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    الإتاحة: https://doi.org/10.1186/1742-4690-9-S2-P285Test
    https://www.hal.inserm.fr/inserm-00731767Test
    https://www.hal.inserm.fr/inserm-00731767/documentTest
    https://www.hal.inserm.fr/inserm-00731767/file/1742-4690-9-S2-P285.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث